Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Takeda Pharmaceutical Co ( (JP:4502) ) has shared an update.
Takeda Pharmaceutical Company has announced the continuation of its stock compensation plans for directors and management in Japan, initially introduced in 2014 and 2016. These plans aim to align the interests of directors with shareholders by linking compensation to company performance, thereby enhancing corporate value and ensuring effective supervisory functions.
More about Takeda Pharmaceutical Co
Takeda Pharmaceutical Company Limited is a global pharmaceutical company based in Japan. It is involved in the research, development, manufacturing, and marketing of pharmaceutical products, with a focus on oncology, gastroenterology, neuroscience, and rare diseases.
Average Trading Volume: 5,242,277
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen7003.9B
Find detailed analytics on 4502 stock on TipRanks’ Stock Analysis page.